Anbio Biotechnology (NNNN) Equity Ratio (2023 - 2025)

Anbio Biotechnology has reported Equity Ratio over the past 3 years, most recently at 1.0 for Q4 2025.

  • Quarterly results put Equity Ratio at 1.0 for Q4 2025, up 9.74% from a year ago — trailing twelve months through Dec 2025 was 1.0 (up 9.74% YoY), and the annual figure for FY2025 was 1.0, up 9.74%.
  • Equity Ratio for Q4 2025 was 1.0 at Anbio Biotechnology, up from 0.91 in the prior quarter.
  • Over the last five years, Equity Ratio for NNNN hit a ceiling of 1.0 in Q4 2025 and a floor of 0.91 in Q4 2024.
  • Median Equity Ratio over the past 3 years was 0.94 (2023), compared with a mean of 0.95.
  • Biggest five-year swings in Equity Ratio: decreased 3.06% in 2024 and later rose 9.74% in 2025.
  • Anbio Biotechnology's Equity Ratio stood at 0.94 in 2023, then decreased by 3.06% to 0.91 in 2024, then increased by 9.74% to 1.0 in 2025.
  • The last three reported values for Equity Ratio were 1.0 (Q4 2025), 0.91 (Q4 2024), and 0.94 (Q4 2023) per Business Quant data.